Author:
Sidwell R W,Huffman J H,Call E W,Alaghamandan H,Cook P D,Robins R K
Abstract
Activity of the new antiviral compound selenazofurin was compared with the known active compounds ribavirin and amantadine against influenza A and B viruses. In experiments with Madin Darby canine kidney cells, selenazofurin inhibited the cytopathic effect and yield of influenza A/NWS/33 virus, with 50% effective dose ranges of 0.7 to 1.4 micrograms/ml (virus rating [VR], 1.3 to 1.4). The 50% effective dose range for ribavirin was 1.2 to 1.6 micrograms/ml (VR, 1.0 to 1.3), and for amantadine it was 9 micrograms/ml (VR, 0.9). Selenazofurin and ribavirin were similarly inhibitory to influenza B/Lee/40 virus, whereas amantadine was inactive. Selenazofurin appeared somewhat cytotoxic in these studies at concentrations as low as 1 micrograms/ml.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Antiviral activity of 1-adamantanamine (Amantadine);Davies W. L.;Science,1964
2. In vitro effect of 1-p-Dribofuranosy1-1,2,4-triazole-3-carboxamide (Virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses;Huffman J. H.;Antimicrob. Agents Chemother.,1973
3. Suppression by 1-,-D-ribofuranosy1-1,2,4- triazole-3-carboxamide (Virazole, ICN 1229) of influenza virusinduced infections in mice;Khare G. P.;Antimicrob. Agents Chemother.,1973
4. Broad-spectrum antiviral activity of 2-13-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent;Kirsi J. J.;Antimicrob. Agents Chemother.,1983
5. Knight V. S. Z. Wilson J. M. Quarles S. E. Greggs H. W. McClung B. K. Waters R. W. Cameron J. M. Zerwas and R. B. Couch. 1981. Ribavirin small-particle aerosol treatment of influenza. Lancet ii:945-949.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献